Disruption of the ATM gene in breast cancer

Cancer Genetics and Cytogenetics

Volumn 126, Issue 2, 2001, Pages 97-101

  Lu, Yong Jie ^a   Condie, Alison ^a   Bennett, Julie D ^a   Fry, Michael J ^a   Yuille, Martin R ^a   Shipley, Janet ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROCHROME;

ARTICLE; BREAST CARCINOMA; CELL LINE; CELL NUCLEUS; CHROMATIN; CHROMOSOME ANALYSIS; COSMID; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DISRUPTION; GENE DOSAGE; GENE FUNCTION; HUMAN; HUMAN CELL; PLOIDY; PRIORITY JOURNAL;

EID: 0035870704     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(00)00401-5     Document Type: Article

References (16)

1. Athma P., Rappoport R., Swift M. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet. 92:1996;130-134.
2. Gatti R., Tward A., Concannon P. Cancer risk in ATM heterozygotes. a model of phenotypic and mechanistic differences between missense and truncating mutations Mol Genet Metab. 68:1999;419-423.
3. Laake K., Odegard A., Andersen T.I., Bukholm I.K., Karesen R., Nesland J.M., Ottestad L., Shiloh Y., Borresen-Dale A.L. Loss of heterozygosity at 11q23.1 in breast carcinomas. indication for involvement of a gene distal and close to ATM Genes Chromosom Cancer. 18:1997;175-180.
4. Vorechovsky I., Rasio D., Luo L., Monaco C., Hammarstrom L., Webster A.D.B., Zaloudik J., Barbanti-Brodano G., James M., Russo G., Croce C.M., Negrini M. The ATM gene and susceptibility to breast cancer. analysis of 38 breast tumors reveals no evidence for mutation Cancer Res. 56:1996;2726-2732.
5. Xu Y., Baltimore D. Dual roles of ATM in the cellular response to radiation and in cell growth control. Genes Dev. 10:1996;2401-2410.
6. McConville C.M., Stankovic T., Byrd P.J., McGuire G.M., Yao Q.Y., Lennox G.G., Taylor A.M.R. Mutations associated with variant phenotypes in ataxia-telangiectasia. Am J Hum Genet. 59:1996;320-330.
7. Smith L., Liu S.J., Goodrich L., Jacobson D., Degnin C., Bentley N., Carr A., Flaggs G., Keegan K., Hoekstra M., Thayer M.J. Duplication of ATR inhibits MyoD, induces aneuploidy and eliminates radiation-induced G1 arrest. Nat Genet. 19:1998;39-46.
8. Waha A., Sturne C., Kessler A., Koch A., Kreyer E., Flimmers R., Wiestler O.D., von Deimling A., Krebs D., Schmutzler R.K. Expression of the ATM gene is significantly reduced in sporadic breast carcinomas. Int J Cancer. 78:1998;306-309.
9. Weber-Hall S.J., McManus A., Anderson J., Nojima T., Abe S., Pritchard-Jones K., Shipley J. Novel formation and amplification of the PAX7-FKHR fusion gene in a case of alveolar rhabdomyosarcoma. Genes Chromosom Cancer. 17:1996;7-13.
10. Yuille M.A., Coignet L.J., Abraham S.M., Yaqub F., Luo L., Matutes E., Brito-Babapulle V., Vorechovsky I., Dyer M.J., Catovsky D. ATM is usually rearranged in T-cell prolymphocytic leukaemia. Oncogene. 16:1998;789-796.
11. Koreth J., Bakkenist C.J., Larin Z., Hunt N.C., James M.R., McGee J.O. 11q23.1 and 11q25-qter YACs suppress tumour growth in vivo. Oncogene. 4:1999;1157-1164.
12. Negrini M., Sabbioni S., Possati L., Rattan S., Corallini A., Barbanti-Brodano G., Croce C.M. Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer. studies on chromosomes 6 and 11 Cancer Res. 54:1994;1331-1336.
13. Morgan S.E., Lovly C., Pandita T.K., Shiloh Y., Kastan M.B. Fragments of ATM which have dominant negative or complementing activity. Mol Cell Biol. 17:1997;2020-2029.
14. Vorechovsky I., Luo L., Dyer M., Catovsky D., Amlot P.L., Yaxley J.C., Foroni L., Hammarstrom L., Webster A.D., Yuille M. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat Genet. 17:1997;96-99.
15. Bullrich F., Rasio D., Kitada S., Starostik P., Kipps T., Keating M., Albitar M., Reed J., Croce C. ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res. 59:1999;24-27.
16. Stankovic T., Weber P., Stewart G., Bedenham T., Murray J., Byrd P.J., Moss P.A.H., Taylor M.R. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet. 353:1999;26-29.